BioHealth News
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the commercial expansion into Inborn Errors of…
Read More
Boost Your Summer Team with Top Talent: UMD Smith School’s Graduate Internship Program Offers $1,500 Reimbursement Per Intern
This summer, your business can tap into Maryland’s top graduate business talent and get rewarded for it. The Maximizing Maryland Graduate Internship Program, run…
Read More
Save the Date & Sponsor the Future: BioHealth Capital Region Week Returns September 23–25, 2025
Mark your calendars! The 11th Annual BioHealth Capital Region Forum will return September 23rd–24th, 2025, once again hosted at US Pharmacopeia (USP) in Rockville,…
Read More
Quoin Pharmaceuticals Announces Additional Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study and Approval to Initiate Testing of a Second Pediatric Patient
ASHBURN, Va., April 02, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a late clinical stage, specialty pharmaceutical company…
Read More
IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of MIND Institute
POTOMAC, MD / ACCESS Newswire / April 1, 2025 / IGC Pharma, Inc. (NYSE American:IGC) today announced the expansion of its Phase 2 clinical trial, CALMA, evaluating…
Read More
Vanda Submits New Drug Application to FDA for Bysanti™ to Treat Bipolar I Disorder and Schizophrenia
WASHINGTON, March 31, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that a New Drug Application (NDA) was submitted to the U.S. Food and…
Read More
The Frederick News-Post: Leidos loses contract to operate Frederick cancer research lab at Fort Detrick
Gabrielle Lewis, The Frederick News-Post, Md. - Thu, January 23, 2025 at 11:59 PM EST - Leidos Biomedical Research, a federal contractor that has…
Read More
BIO survey: Tariffs threaten innovation, access to cures
U.S. tariffs on imports could increase the cost of biotechnology operations, threatening innovation that helps patients, according to a survey of biotech firms by…
Read More
‘Business of Life Sciences and Healthcare for Leaders’ Forthcoming from UMD Smith Executive Education
COLLEGE PARK, Md., March 26, 2025 /PRNewswire/ -- Registration is open for "Business of Life Sciences and Healthcare for Leaders" (B-LSHC) — an immersive five-day program…
Read More
RAPPNEWS: George Mason University celebrates $107M life sciences and engineering building in Manassas
Emily Seymour | InsideNoVa Mar 28, 2025 - George Mason University held the grand opening of its new life sciences and engineering building in…
Read More
BISNOW: Fueled By A Strong Pipeline, Prince William County Is A Thriving Alternative For Emerging Life Sciences Innovators
March 25, 2025 - John Knowles, Studio B Writer - The BioCapital Region, which includes Washington, D.C., Maryland and Virginia, is one of the…
Read More
Elutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro™
SILVER SPRING, Md., March 27, 2025 (GLOBE NEWSWIRE) — Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, announced…
Read More
CorVista Health Presents New Data on Non-Invasive Point of Care Testing for Pulmonary Capillary Wedge Pressure (PCWP) Elevation Using Machine Learning
BETHESDA, Md., March 31, 2025 (GLOBE NEWSWIRE) -- CorVista Health today announced a poster presentation showcasing preliminary results of its machine learning-based algorithm for…
Read More
CoStar: A life sciences field of dreams takes shape with the opening of 4MLK
By Dan Beyers, Katelyn Keiser - CoStar News - March 26, 2025 - If there is a field of dreams in Baltimore these days, it might be…
Read More
Solaxa Announces Phase 3 Clinical Trial for Spinocerebellar Ataxia Type 27B
Bethesda, MD — March 28, 2025 – Solaxa Inc., a biopharmaceutical public benefit corporation focused on rare neurological conditions, has announced plans to conduct a registrational clinical…
Read More